Registry on data collected from patients with mastocytosis in Europe
Recruiting
- Conditions
- D47.0Histiocytic and mast cell tumours of uncertain and unknown behaviour
- Registration Number
- DRKS00007995
- Lead Sponsor
- Klinik für Innere Medizin IAbteilung für Hämatologie und HämostaseologieMedizinische Universität Wien
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 2000
Inclusion Criteria
All patients with mastocytosis diagnosed since January 1990 in the participating european centers.
Exclusion Criteria
none.
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method · Percentage of patients in each category of mastocytosis in Europe<br>· Percentage of patients in each category of mastocytosis in Europe in different<br>European regions<br>· Gender and age distribution of patients with mastocytosis in Europe
- Secondary Outcome Measures
Name Time Method Percentage of patients who show progression to frank aggressive mastocytosis<br>or AHNMD<br>· Time to progression<br>· Survival of patients with mastocytosis<br>· Occurrence of mediator symptoms<br>· Determination of risk factors predicting the progression as well as the resulting<br>survival and/or outcome in patients fulfilling the criteria of mastocytosis.<br>· Response to mediator therapy administered in routine